Global Human Rotavirus Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 156588
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 109
  • list Pharmaceuticals and Healthcare

Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.

Scope of the Report:

This report focuses on the Human Rotavirus Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.

The worldwide market for Human Rotavirus Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Bharat Biotech

Merck

GlaxoSmithKline

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Rotarix

RotaTeq

Rotavac

Rotavin-M1

Lanzhou lamb

Others

Market Segment by Applications, can be divided into

Hospitals & Clinics

Academic And Research

Others

There are 15 Chapters to deeply display the global Human Rotavirus Vaccine market.

Chapter 1, to describe Human Rotavirus Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Rotavirus Vaccine, with sales, revenue, and price of Human Rotavirus Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Rotavirus Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Human Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Human Rotavirus Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Human Rotavirus Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Rotarix

1.2.2 RotaTeq

1.2.3 Rotavac

1.2.4 Rotavin-M1

1.2.5 Lanzhou lamb

1.2.6 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals & Clinics

1.3.2 Academic And Research

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Bharat Biotech

2.1.1 Business Overview

2.1.2 Human Rotavirus Vaccine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck

2.2.1 Business Overview

2.2.2 Human Rotavirus Vaccine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Merck Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 Human Rotavirus Vaccine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Human Rotavirus Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Human Rotavirus Vaccine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Human Rotavirus Vaccine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Human Rotavirus Vaccine Manufacturer Market Share in 2017

3.3.2 Top 6 Human Rotavirus Vaccine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Human Rotavirus Vaccine Market Analysis by Regions

4.1 Global Human Rotavirus Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Human Rotavirus Vaccine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Human Rotavirus Vaccine Revenue and Market Share by Regions (2013-2018)

4.2 North America Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

4.3 Europe Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

4.5 South America Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

5 North America Human Rotavirus Vaccine by Countries

5.1 North America Human Rotavirus Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Human Rotavirus Vaccine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Human Rotavirus Vaccine Revenue and Market Share by Countries (2013-2018)

5.2 United States Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

5.3 Canada Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

5.4 Mexico Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

6 Europe Human Rotavirus Vaccine by Countries

6.1 Europe Human Rotavirus Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Human Rotavirus Vaccine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Human Rotavirus Vaccine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

6.3 UK Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

6.4 France Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

6.5 Russia Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

6.6 Italy Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Human Rotavirus Vaccine by Countries

7.1 Asia-Pacific Human Rotavirus Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Human Rotavirus Vaccine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Human Rotavirus Vaccine Revenue and Market Share by Countries (2013-2018)

7.2 China Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

7.3 Japan Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

7.4 Korea Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

7.5 India Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

8 South America Human Rotavirus Vaccine by Countries

8.1 South America Human Rotavirus Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Human Rotavirus Vaccine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Human Rotavirus Vaccine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

8.3 Argentina Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

8.4 Colombia Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Human Rotavirus Vaccine by Countries

9.1 Middle East and Africa Human Rotavirus Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Human Rotavirus Vaccine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Human Rotavirus Vaccine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

9.3 UAE Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

9.4 Egypt Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

9.5 Nigeria Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

9.6 South Africa Human Rotavirus Vaccine Sales and Growth Rate (2013-2018)

10 Global Human Rotavirus Vaccine Market Segment by Type

10.1 Global Human Rotavirus Vaccine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Human Rotavirus Vaccine Sales and Market Share by Type (2013-2018)

10.1.2 Global Human Rotavirus Vaccine Revenue and Market Share by Type (2013-2018)

10.2 Rotarix Sales Growth and Price

10.2.1 Global Rotarix Sales Growth (2013-2018)

10.2.2 Global Rotarix Price (2013-2018)

10.3 RotaTeq Sales Growth and Price

10.3.1 Global RotaTeq Sales Growth (2013-2018)

10.3.2 Global RotaTeq Price (2013-2018)

10.4 Rotavac Sales Growth and Price

10.4.1 Global Rotavac Sales Growth (2013-2018)

10.4.2 Global Rotavac Price (2013-2018)

10.5 Rotavin-M1 Sales Growth and Price

10.5.1 Global Rotavin-M1 Sales Growth (2013-2018)

10.5.2 Global Rotavin-M1 Price (2013-2018)

10.6 Lanzhou lamb Sales Growth and Price

10.6.1 Global Lanzhou lamb Sales Growth (2013-2018)

10.6.2 Global Lanzhou lamb Price (2013-2018)

10.7 Others Sales Growth and Price

10.7.1 Global Others Sales Growth (2013-2018)

10.7.2 Global Others Price (2013-2018)

11 Global Human Rotavirus Vaccine Market Segment by Application

11.1 Global Human Rotavirus Vaccine Sales Market Share by Application (2013-2018)

11.2 Hospitals & Clinics Sales Growth (2013-2018)

11.3 Academic And Research Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Human Rotavirus Vaccine Market Forecast (2018-2023)

12.1 Global Human Rotavirus Vaccine Sales, Revenue and Growth Rate (2018-2023)

12.2 Human Rotavirus Vaccine Market Forecast by Regions (2018-2023)

12.2.1 North America Human Rotavirus Vaccine Market Forecast (2018-2023)

12.2.2 Europe Human Rotavirus Vaccine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Human Rotavirus Vaccine Market Forecast (2018-2023)

12.2.4 South America Human Rotavirus Vaccine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Human Rotavirus Vaccine Market Forecast (2018-2023)

12.3 Human Rotavirus Vaccine Market Forecast by Type (2018-2023)

12.3.1 Global Human Rotavirus Vaccine Sales Forecast by Type (2018-2023)

12.3.2 Global Human Rotavirus Vaccine Market Share Forecast by Type (2018-2023)

12.4 Human Rotavirus Vaccine Market Forecast by Application (2018-2023)

12.4.1 Global Human Rotavirus Vaccine Sales Forecast by Application (2018-2023)

12.4.2 Global Human Rotavirus Vaccine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Human Rotavirus Vaccine Picture

Table Product Specifications of Human Rotavirus Vaccine

Figure Global Sales Market Share of Human Rotavirus Vaccine by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery